Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression

Cell Calcium. 2009 Mar;45(3):284-92. doi: 10.1016/j.ceca.2008.11.006. Epub 2009 Jan 7.

Abstract

Hepatic stellate cells (HSC) are important mediators of liver fibrosis. Hormones linked to downstream intracellular Ca(2+) signals upregulate HSC proliferation, but the mechanisms by which this occurs are unknown. Nuclear and cytosolic Ca(2+) signals may have distinct effects on cell proliferation, so we expressed plasmid and adenoviral constructs containing the Ca(2+) chelator parvalbumin (PV) linked to either a nuclear localization sequence (NLS) or a nuclear export sequence (NES) to block Ca(2+) signals in distinct compartments within LX-2 immortalized human HSC and primary rat HSC. PV-NLS and PV-NES constructs each targeted to the appropriate intracellular compartment and blocked Ca(2+) signals only within that compartment. PV-NLS and PV-NES constructs inhibited HSC growth. Furthermore, blockade of nuclear or cytosolic Ca(2+) signals arrested growth at the G2/mitosis (G2/M) cell-cycle interface and prevented the onset of mitosis. Blockade of nuclear or cytosolic Ca(2+) signals downregulated phosphorylation of the G2/M checkpoint phosphatase Cdc25C. Inhibition of calmodulin kinase II (CaMK II) had identical effects on LX-2 growth and Cdc25C phosphorylation. We propose that nuclear and cytosolic Ca(2+) are critical signals that regulate HSC growth at the G2/M checkpoint via CaMK II-mediated regulation of Cdc25C phosphorylation. These data provide a new logical target for pharmacological therapy directed against progression of liver fibrosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Signaling* / drug effects
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / antagonists & inhibitors
  • Cell Compartmentation / drug effects
  • Cell Cycle* / drug effects
  • Cell Nucleus / drug effects
  • Cell Nucleus / enzymology
  • Cell Proliferation / drug effects
  • Chelating Agents / pharmacology
  • Cytosol / drug effects
  • Cytosol / metabolism
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Enzyme Inhibitors / pharmacology
  • G2 Phase / drug effects
  • Hepatocytes / cytology*
  • Hepatocytes / drug effects
  • Hepatocytes / enzymology
  • Humans
  • Intracellular Space / drug effects
  • Intracellular Space / metabolism*
  • Parvalbumins / metabolism
  • Phosphorylation / drug effects
  • Protein Transport
  • Rats
  • Subcellular Fractions / drug effects
  • Subcellular Fractions / metabolism
  • cdc25 Phosphatases / metabolism

Substances

  • Chelating Agents
  • Enzyme Inhibitors
  • Parvalbumins
  • Egtazic Acid
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • cdc25 Phosphatases
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid